EYPT
$8.69
Eyepoint Pharmaceuticals
($.18)
(2.03%)
EYPT
Earnings Whisper ®
N/A
2nd Quarter June 2021
Consensus:  ($0.44)
Revenue:  $10.80 Mil
Wednesday
Aug 4
7:00 AM ET
Score
Grade
Tweet Share Watch
Tweet Share Watch

What do you expect when EYPT reports earnings?
Beat
Meet
Miss

Where is EYPT's stock price going from here?
Up
Flat
Down
Stock chart of EYPT
Analysts
Summary of analysts' recommendations for EYPT
Score
Grade
Pivots
Resistance
$9.41
$9.14
$8.92

$8.65

Support
$8.42
$8.15
$7.93
Tweet
Growth
Description
EyePoint Pharmaceuticals Inc. operates as a biopharmaceutical company. It engaged in the development of drug devices to treat debilitating diseases of the eye disorders and other chronic conditions. The company's product candidate consists of DEXYCU(TM). EyePoint Pharmaceuticals Inc., formerly known as pSivida Corp., is headquartered in Watertown, MA.